Edges in Network
Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | VCAN |
Upstream (Parents) |
---|
(<<) CRTAP → VCAN |
(<<) THY1 → VCAN |
(<<) POSTN → VCAN |
(<<) COL1A1 → VCAN |
(<<) TAGLN → VCAN |
(<<) FAP → VCAN |
Downstream (Children) |
---|
VCAN → RBMS2 (>>) |
VCAN → SNTB2 (>>) |
VCAN → MAN2A1 (>>) |
VCAN → DFFB (>>) |
VCAN → GUCY1B3 (>>) |
VCAN → CD55 (>>) |
VCAN → MIR21 (>>) |
VCAN → CD99 (>>) |
VCAN → SMYD3 (>>) |
VCAN → TAF5 (>>) |
VCAN → CEP72 (>>) |
VCAN → ASXL1 (>>) |
VCAN → COL15A1 (>>) |
VCAN → C4orf3 (>>) |
VCAN → SCRN1 (>>) |
VCAN → FERMT2 (>>) |
VCAN → NPM1 (>>) |
VCAN → CST1 (>>) |
VCAN → POSTN (>>) |
VCAN → TAGLN (>>) |
VCAN → LAMB1 (>>) |
VCAN → NRP1 (>>) |
VCAN → SMARCA1 (>>) |
VCAN → TIMP1 (>>) |